Status:

COMPLETED

Atlas of Experimental Gingivitis in Humans

Lead Sponsor:

University of North Carolina, Chapel Hill

Collaborating Sponsors:

Sunstar, Inc.

Conditions:

Gingivitis

Eligibility:

All Genders

18-30 years

Phase:

NA

Brief Summary

Pilot case series with a split-mouth design to track subjects with known exposure (dental biofilm accumulation) over 21 days. Descriptive design, using single cell RNA sequencing as a "digital biopsy"...

Detailed Description

Purpose is to conduct the first study of human gingiva in health and after biofilm-induced inflammation in the gingiva using scRNAseq. The pilot will involve induction of experimental gingivitis in al...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Adult males or females between the age of 18 and 30 years.
  • Non-diabetic and no history of smoking within the last 5 years.
  • Have read, understood and signed an informed consent form.
  • Must be able and willing to follow study procedures and instructions.
  • Must have at least 3 natural adjacent teeth in both maxillary (top) posterior sextants that will be selected for baseline gingival biopsy and SIBO gingival biopsy.
  • Must be in good general health, as evidenced by medical hx (exclusion conditions defined under subject exclusion criteria below).
  • Females of childbearing capacity must be willing to have pregnancy test to confirm they are not pregnant.
  • Exclusion Criteria
  • History of intravenous bisphosphonates.
  • Current or history (less than 5 years) of tobacco use in any form prior to enrollment (self-report)
  • Chronic disease with oral manifestations including diabetes mellitus.
  • Infectious disease such as hepatitis, HIV, or tuberculosis.
  • Anemia or other blood dyscrasias.
  • Currently taking anticoagulant therapy or drugs, such as heparin or warfarin.
  • Those requiring antibiotic prophylaxis prior to dental treatment
  • Exhibiting gross oral pathology or a history of periodontal disease.
  • Individuals with a history or are currently using birth control containing hormones.
  • Individuals without a history (less than 1 year) of regular professional oral health care, including prophylaxis. (self-report)
  • Pregnant, breastfeeding or planning for pregnancy within 3 months.
  • Individuals who used antibiotics/chronically used NSAIDs
  • Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.

Exclusion

    Key Trial Info

    Start Date :

    October 15 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 3 2019

    Estimated Enrollment :

    6 Patients enrolled

    Trial Details

    Trial ID

    NCT04105569

    Start Date

    October 15 2019

    End Date

    December 3 2019

    Last Update

    August 12 2020

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Adams School of Dentistry

    Chapel Hill, North Carolina, United States, 27599